Read on Twitter
Comprehensive approach by Ray Deshaies of @Amgen re: working with @AdaptiveBiotech to search for #COVIDー19 antibodies & merging data with @Decode_Science Adaptive: Algos to search for neutralizing antibodies Decode: Studying recovered patients in #Iceland https://otter.ai/s/nE2ZNvDzQbK9PTB3PGEOOg
What's your take on this approach, @rtnarch? "Identify antibodies...Produce in large quantities...look at genetic information [for patient selection]"
Source: https://wwwext.amgen.com/media/featured-news/2020/04/can-therapeutic-antibodies-offer-hope-for-covid-19-patients/ @LifeSciVC @Dereklowe @mattocko @MichaelPellini @DrCJ_Houldcroft @stewartbrand @jaybradner
Source: https://wwwext.amgen.com/media/featured-news/2020/04/can-therapeutic-antibodies-offer-hope-for-covid-19-patients/ @LifeSciVC @Dereklowe @mattocko @MichaelPellini @DrCJ_Houldcroft @stewartbrand @jaybradner
From Chad Robins, CEO of $ADPT: "Our immune medicine platform will focus on B cells responding to recent infection and screen tens of thousands of antibody secreting cells derived from patients who have recovered from COVID-19" https://www.adaptivebiotech.com/ceo-chad-robins-on-strategic-partnership-with-amgen-to-develop-therapeutic-antibodies-against-covid-19/
What's the key difference between Amgen+Adaptive+Decode approach vs. the recently announced @GSK/ @Vir_Biotech deal? https://www.gsk.com/en-gb/media/press-releases/gsk-and-vir-biotechnology-enter-collaboration-to-find-coronavirus-solutions/
Hi @Varro_Analytics, your thoughts on this thread...what’s the key difference between $ADPT & $VIR for approach to #COVID19?
